Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-23-016525)

Filing Details

Accession Number:: 0001127602-23-016525
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-23 08:06:26
Reporting Period:: 2023-05-19

Accepted Time:: 2023-05-23 08:06:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
920148	Laboratory Corp Of America Holdings	LH	Services-Medical Laboratories (8071)	133757370

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791393	R Paul Kirchgraber	531 South Spring Street Burlington NC 27215	Ceo, Covance Drug Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-19	4,300	$182.51	17,246	No	4	M	Direct
Common Stock	Disposition	2023-05-19	4,300	$216.91	12,946	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-qualified Stock Options	Disposition	2023-05-19	4,300	$0.00	4,300	$182.51

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2021-02-04	2030-02-03	No	4	M	Direct

Footnotes

Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
The option vested in three equal annual installments beginning on the date reflected in this column.